2.24
price up icon4.67%   0.10
after-market Dopo l'orario di chiusura: 2.26 0.02 +0.89%
loading

Creative Medical Technology Holdings Inc Borsa (CELZ) Ultime notizie

pulisher
Apr 02, 2025

Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN

Apr 02, 2025
pulisher
Mar 30, 2025

Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World

Mar 30, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Mergers & Acquisitions Tracker - Plastics News

Mar 24, 2025
pulisher
Mar 24, 2025

What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 21, 2025

Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

FDA approves expanded trial for back pain cell therapy - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times

Mar 20, 2025
pulisher
Mar 19, 2025

Nanoparticle Drug Delivery Market Growth, Generated - openPR.com

Mar 19, 2025
pulisher
Mar 18, 2025

Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 16, 2025

Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo

Mar 16, 2025
pulisher
Mar 16, 2025

When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Delaware Court Just Changed the Game for Big Business - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Trump Tariffs in Chaos: Markets React - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Revolutionary: Medical Stem Cells Unlock Profit for CELZ - GeeksULTD

Mar 16, 2025
pulisher
Mar 16, 2025

Breaking: Trump Trade War Exposes Hidden Dangers - GeeksULTD

Mar 16, 2025
pulisher
Mar 14, 2025

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC 10-K Report - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners - The Malaysian Reserve

Mar 13, 2025
pulisher
Mar 13, 2025

Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR

Mar 13, 2025
pulisher
Mar 10, 2025

Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi - EIN News

Mar 10, 2025
pulisher
Mar 07, 2025

Creative Medical Technology secures $3.7 million through warrants By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Where are the Opportunities in (CELZ) - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology secures $3.7 million through warrants - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross - EIN News

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Heritage Distilling Co. Announces Recent Achievements and Key Milestones for Salute Series Line of Premium Whiskeys - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Creative Medical Technology Holdings Announces Agreements For Exercise Of Warrants For $3.7 Million Gross Proceeds - MENAFN.COM

Mar 06, 2025
pulisher
Mar 06, 2025

Can This $3.7M Cash Injection Fuel Creative Medical's Next Growth Phase? - StockTitan

Mar 06, 2025
pulisher
Mar 04, 2025

Head to Head Analysis: Cognition Therapeutics (NASDAQ:CGTX) versus Creative Medical Technology (NASDAQ:CELZ) - Defense World

Mar 04, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 16,291 Shares of DNOW Inc. (NYSE:DNOW) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 7,443 Shares of WisdomTree, Inc. (NYSE:WT) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Acquires 3,900 Shares of Vertex, Inc. (NASDAQ:VERX) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Cuts Position in American Assets Trust, Inc. (NYSE:AAT) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Purchases 3,454 Shares of Spirit AeroSystems Holdings, Inc. (NYSE:SPR) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Sells 314 Shares of S&T Bancorp, Inc. (NASDAQ:STBA) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Embecta Corp. (NASDAQ:EMBC) Shares Sold by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Reduces Position in TowneBank (NASDAQ:TOWN) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Ambarella, Inc. (NASDAQ:AMBA) Shares Sold by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Lowers Holdings in Harmonic Inc. (NASDAQ:HLIT) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

MaxLinear, Inc. (NASDAQ:MXL) Stake Lifted by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

DA Davidson Comments on Grocery Outlet Q1 Earnings - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Alphatec Target of Unusually Large Options Trading (NASDAQ:ATEC) - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Sanctuary Advisors LLC Buys 1,374 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

CELZCreative Med Technology Hldgs Latest Stock News & Market Updates - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Head to Head Analysis: Kymera Therapeutics (NASDAQ:KYMR) and Creative Medical Technology (NASDAQ:CELZ) - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

How the (CELZ) price action is used to our Advantage - Stock Traders Daily

Feb 24, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):